Stephen J Nicholls

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	67729	36638
h-endeksi	109	79
i10-endeksi	434	351

10000

5000

2500

7500

20062007200820092010201120122013201420152016201720182019202020212022202320242025401 842 1409 1616 1600 1803 1997 2340 2664 2705 2984 3146 3212 3306 4173 6108 7448 8001 9373 1122

Genel erişim

Tümünü görüntüle

187 makale

48 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Rishi PuriCardiovascular Medicine, Cleveland Clinicccf.org üzerinde doğrulanmış e-posta adresine sahip
Philip BarterUnivrsity of New South Wales Australiaunsw.edu.au üzerinde doğrulanmış e-posta adresine sahip
Christie BallantyneBaylor College of Medicinebcm.edu üzerinde doğrulanmış e-posta adresine sahip
A. Michael LincoffProfessor of Medicine, Cleveland Clinicccf.org üzerinde doğrulanmış e-posta adresine sahip
Paul SchoenhagenProfessor of Radiology, Cleveland Clinicccf.org üzerinde doğrulanmış e-posta adresine sahip
Peter PsaltisThe University of Adelaide, South Australian Health and Medical Research Institute and CALHNsahmri.com üzerinde doğrulanmış e-posta adresine sahip
Ilke SipahiProf. Dr. ILKE SIPAHI Muayenehanesiilkesipahi.com üzerinde doğrulanmış e-posta adresine sahip
Kausik Kumar RayProfessor of Public Health, Imperial College Londonimperial.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Stanley L HazenCleveland Clinicccf.org üzerinde doğrulanmış e-posta adresine sahip
Adam J NelsonCALHN | UofA | VHI | DCRIadelaide.edu.au üzerinde doğrulanmış e-posta adresine sahip
Peter LibbyProfessor of Medcine Harvard Medical Schoolbwh.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Christina BursillThe University of Adelaidesahmri.com üzerinde doğrulanmış e-posta adresine sahip
John CHAPMANSorbonne University and Pitie-Salpetriere University Hospitalupmc.fr üzerinde doğrulanmış e-posta adresine sahip
Belinda Di BartoloThe University of Sydneysydney.edu.au üzerinde doğrulanmış e-posta adresine sahip
Kerry-Anne RyeUniversity of New South Walesunsw.edu.au üzerinde doğrulanmış e-posta adresine sahip
Matthew WorthleyAssociate Professor, University of Adelaideadelaide.edu.au üzerinde doğrulanmış e-posta adresine sahip
Gemma FigtreeProfessor, Sydney Medical School (Northern), University of Sydneysydney.edu.au üzerinde doğrulanmış e-posta adresine sahip
John BeltrameProfessor of Medicine - Michell Chair, University of Adelaideadelaide.edu.au üzerinde doğrulanmış e-posta adresine sahip
celermajerprofessor of cardiology, university of sydneyemail.cs.nsw.gov.au üzerinde doğrulanmış e-posta adresine sahip
Leonard KritharidesCardiologist, Professor of Medicine University of Sydneysydney.edu.au üzerinde doğrulanmış e-posta adresine sahip

Takip et

Stephen J Nicholls

Monash University

monash.edu üzerinde doğrulanmış e-posta adresine sahip


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Cardiovascular and renal outcomes with empagliflozin in heart failure M Packer, SD Anker, J Butler, G Filippatos, SJ Pocock, P Carson, ... New England Journal of Medicine 383 (15), 1413-1424, 2020	4712	2020
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European … BA Ference, HN Ginsberg, I Graham, KK Ray, CJ Packard, E Bruckert, ... European heart journal 38 (32), 2459-2472, 2017	3822	2017
Empagliflozin in heart failure with a preserved ejection fraction SD Anker, J Butler, G Filippatos, JP Ferreira, E Bocchi, M Böhm, ... New England Journal of Medicine 385 (16), 1451-1461, 2021	3814	2021
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial SE Nissen, SJ Nicholls, I Sipahi, P Libby, JS Raichlen, CM Ballantyne, ... Jama 295 (13), 1556-1565, 2006	3269	2006
Effects of dalcetrapib in patients with a recent acute coronary syndrome GG Schwartz, AG Olsson, M Abt, CM Ballantyne, PJ Barter, J Brumm, ... New England Journal of Medicine 367 (22), 2089-2099, 2012	2359	2012
Antiinflammatory properties of HDL PJ Barter, S Nicholls, KA Rye, GM Anantharamaiah, M Navab, ... Circulation research 95 (8), 764-772, 2004	1764	2004
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials AM Lincoff, K Wolski, SJ Nicholls, SE Nissen Jama 298 (10), 1180-1188, 2007	1703	2007
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European … J Boren, MJ Chapman, RM Krauss, CJ Packard, JF Bentzon, CJ Binder, ... European heart journal 41 (24), 2313-2330, 2020	1350	2020
Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial SJ Nicholls, R Puri, T Anderson, CM Ballantyne, L Cho, JJP Kastelein, ... Jama 316 (22), 2373-2384, 2016	1239	2016
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis M Jun, C Foote, J Lv, B Neal, A Patel, SJ Nicholls, DE Grobbee, A Cass, ... The Lancet 375 (9729), 1875-1884, 2010	1232	2010
Effect of torcetrapib on the progression of coronary atherosclerosis SE Nissen, JC Tardif, SJ Nicholls, JH Revkin, CL Shear, WT Duggan, ... New England Journal of Medicine 356 (13), 1304-1316, 2007	1197	2007
Effect of two intensive statin regimens on progression of coronary disease SJ Nicholls, CM Ballantyne, PJ Barter, MJ Chapman, RM Erbel, P Libby, ... New England Journal of Medicine 365 (22), 2078-2087, 2011	1182	2011
Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial SE Nissen, SJ Nicholls, K Wolski, R Nesto, S Kupfer, A Perez, H Jure, ... Jama 299 (13), 1561-1573, 2008	1038	2008
Myeloperoxidase and cardiovascular disease SJ Nicholls, SL Hazen Arteriosclerosis, thrombosis, and vascular biology 25 (6), 1102-1111, 2005	1014	2005
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis SJ Nicholls, EM Tuzcu, I Sipahi, AW Grasso, P Schoenhagen, T Hu, ... Jama 297 (5), 499-508, 2007	998	2007
Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial SJ Nicholls, AM Lincoff, M Garcia, D Bash, CM Ballantyne, PJ Barter, ... Jama 324 (22), 2268-2280, 2020	841	2020
Protein carbamylation links inflammation, smoking, uremia and atherogenesis Z Wang, SJ Nicholls, ER Rodriguez, O Kummu, S Hörkkö, J Barnard, ... Nature medicine 13 (10), 1176-1184, 2007	823	2007
Evacetrapib and cardiovascular outcomes in high-risk vascular disease AM Lincoff, SJ Nicholls, JS Riesmeyer, PJ Barter, HB Brewer, KAA Fox, ... New England Journal of Medicine 376 (20), 1933-1942, 2017	802	2017
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk T Bhattacharyya, SJ Nicholls, EJ Topol, R Zhang, X Yang, D Schmitt, X Fu, ... Jama 299 (11), 1265-1276, 2008	679	2008
Association of triglyceride-lowering LPL variants and LDL-C–lowering LDLR variants with risk of coronary heart disease BA Ference, JJP Kastelein, KK Ray, HN Ginsberg, MJ Chapman, ... Jama 321 (4), 364-373, 2019	669	2019

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar